Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
ability to apply fundamental nursing assessment and triage via telephone, electronic systems and in person to patients receiving chemotherapy, biotherapy and/or stem cell transplant Demonstrated knowledge
-
Institute of Animal Reproduction and Food Research of Polish Academy of Sciences | Poland | 2 months ago
Responsibilities • Isolation of CD34⁺ hematopoietic stem and progenitor cells from cord blood donors for in vitro studies. • Preparation of RNA and chromatin libraries for NGS (RNA-seq, ATAC-seq, ChIPmentation
-
Leukemia DC15: Novel preclinically-validated GATA3 inhibitor/degrader as a therapy for T-cell Acute Lymphoblastic Leukemia DC16: Targeting Metabolic Pathways in Leukemic Stem Cells for AML Treatment
-
Preferred Qualifications: Experience as a Clinical Nurse Practitioner or Physician Assistant Prior clinical experience in Hematology-Oncology or Stem Cell Transplant Advanced Cardiac Life Support (ACLS
-
nearly every area of health. We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community
-
. Dynamic preservation using perfusion machines allows control of IR, and we have demonstrated the efficacy of a cellular therapy derived from urine progenitor cells. Despite the protective and promising
-
the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of people with many skills and talents. We seek candidates whose work experience or
-
of scientific publications in relevant fields. Experience with models of myopathies or inflammation. Familiarity with stem cell-derived muscle models or 3D culture systems (including physiological
-
nearly every area of health. We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community
-
release of cell therapy products. At UCI, the cGMP facility will enable clinical trials of cell therapeutics, including stem cell populations and bone marrow transplantation, as well as Chimeric Antigen